A Nanoparticle-Poly(I:C) Combination Adjuvant Enhances the Breadth of the Immune Response to Inactivated Influenza Virus Vaccine in Pigs
暂无分享,去创建一个
Fangjia Lu | S. Dhakal | G. Renukaradhya | S. Krakowka | S. Ghimire | S. Renu | J. Schrock | Yi Han | H. Hogenesch | V. Patil | N. feliciano-ruiz
[1] S. Dhakal,et al. Poly(I:C) augments inactivated influenza virus-chitosan nanovaccine induced cell mediated immune response in pigs vaccinated intranasally. , 2020, Veterinary microbiology.
[2] S. Dhakal,et al. Oral Deliverable Mucoadhesive Chitosan-Salmonella Subunit Nanovaccine for Layer Chickens , 2020, International journal of nanomedicine.
[3] Fangjia Lu,et al. Corn-derived alpha-D-glucan nanoparticles as adjuvant for intramuscular and intranasal immunization in pigs. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[4] B. Narasimhan,et al. Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry , 2018, International journal of nanomedicine.
[5] Xingguo Cheng,et al. Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs , 2018, International journal of nanomedicine.
[6] S. Ichimiya,et al. Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants , 2018, Journal of Innate Immunity.
[7] Fangjia Lu,et al. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs , 2018, Front. Immunol..
[8] Y. Yao,et al. Alpha-D-glucan nanoparticulate adjuvant induces a transient inflammatory response at the injection site and targets antigen to migratory dendritic cells , 2017, npj Vaccines.
[9] K. Kang,et al. Polyanhydride nanovaccine against swine influenza virus in pigs. , 2017, Vaccine.
[10] K. Kang,et al. Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell‐mediated immune response in pigs , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[11] S. Suradhat,et al. Generation of potent porcine monocyte-derived dendritic cells (MoDCs) by modified culture protocol. , 2016, Veterinary immunology and immunopathology.
[12] K. Kang,et al. Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs , 2016, PloS one.
[13] Y. Yao,et al. Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[14] R. Kaushik,et al. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs , 2014, Vaccine.
[15] A. Takada,et al. Comparison of Antiviral Activity between IgA and IgG Specific to Influenza Virus Hemagglutinin: Increased Potential of IgA for Heterosubtypic Immunity , 2014, PloS one.
[16] Qian Yang,et al. Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken. , 2013, Poultry science.
[17] B. Janke,et al. Clinicopathological features of Swine influenza. , 2013, Current topics in microbiology and immunology.
[18] Wenjun Ma,et al. Swine influenza virus vaccines: to change or not to change-that's the question. , 2013, Current topics in microbiology and immunology.
[19] Tadaki Suzuki,et al. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. , 2012, Vaccine.
[20] D. Irvine,et al. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction , 2012, Proceedings of the National Academy of Sciences.
[21] L. Larsen,et al. Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs , 2011, Virology Journal.
[22] Barbara Wieland,et al. Prevalence and risk factors for swine influenza virus infection in the English pig population , 2011, PLOS Currents.
[23] Amy L. Vincent,et al. Chapter 3 Swine Influenza Viruses , 2008 .
[24] A. Vincent,et al. Swine influenza viruses a North American perspective. , 2008, Advances in virus research.
[25] T. Ichinohe,et al. Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine , 2007, The Journal of infectious diseases.
[26] T. Ichinohe,et al. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection. , 2006, Microbes and infection.
[27] S. Dee,et al. γδ lymphocyte response to porcine reproductive and respiratory syndrome virus , 2005 .
[28] T. Ichinohe,et al. Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection , 2005, Journal of Virology.
[29] S. Dee,et al. Gammadelta lymphocyte response to porcine reproductive and respiratory syndrome virus. , 2005, Viral immunology.
[30] P. Wright,et al. Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract1 , 2004, The Journal of Immunology.
[31] P. Heinen,et al. Analysis of the quality of protection induced by a porcine influenza A vaccine to challenge with an H3N2 virus. , 2001, Veterinary immunology and immunopathology.
[32] F. Belardelli,et al. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.
[33] T. D. de Bruin,et al. Cytolytic function for pseudorabies virus-stimulated porcine CD4+ CD8dull+ lymphocytes. , 2000, Viral immunology.
[34] M. Russell,et al. Nasal Lymphoid Tissue (NALT) as a Mucosal Immune Inductive Site , 1997, Scandinavian journal of immunology.
[35] A. Arsenault,et al. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. , 1997, American journal of respiratory and critical care medicine.